Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open, Randomized, Controlled Phase Ⅱ Clinical Study of Ruxian Zengsheng No. 1 Decoction in Treating Liver-stagnation and Qi-stagnation Hyperplasia of Breast

NCT04767620 is registered in ClinicalTrials.gov with Jiuda Zhao as lead sponsor.

NCT NCT04767620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04767620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open, Randomized, Controlled Phase Ⅱ Clinical Study of Ruxian Zengsheng No. 1 Decoction in Treating Liver-stagnation and Qi-stagnation Hyperplasia of Breast
Lead sponsor
Jiuda Zhao
Phase
Phase 2
Overall status
Unknown status
Start date
March 1, 2021
Completion date
December 31, 2021
Enrollment
137 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mammary gland hyperplasia